| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/20/2008 | US20080070921 Melanocortin receptor modulators; sexual disorders, obesity, cachexia, eating disorders; for example 1,4-bis(2-amino-3-p-tolyl-propionyl)-2-isobutyl-5-(4-(2-aminoethylamino)butyl)piperazine |
| 03/20/2008 | US20080070916 Treating disorders such as proliferative diseases, and cancer; compounds can act as probes of biological function; libraries; for example, 2-ethoxy-3-(2-hydroxyethoxyethoxyethyl)-4-(1-acetylindol-3-yl)-6-(morpholinocarbonyl)-2H-3,4-dihydropyran |
| 03/20/2008 | US20080070915 Poly(ADP-ribose)polymerase (PARP); ischemia, reperfusion injuries, neurological disorders, neuroprotectants, sensitizer for chemotherapy or radiotherapy, anticancer |
| 03/20/2008 | US20080070914 Inhibitors of cell cycle kinases such as cyclin dependent kinase CDK4 and/or the Aurora kinases; use in combination with an anticancer agent |
| 03/20/2008 | US20080070913 Thieno [ 3,2-b] pyridine-6-carbonitriles and thieno [2,3-b] pyridine-5-carbonitriles as protein kinase inhibitors |
| 03/20/2008 | US20080070912 Phosphodiesterase inhibitors; neuropathic pain, inflammation, opioid dependence or withdrawal; 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one for example |
| 03/20/2008 | US20080070910 aromatic or heterocyclic/heterobicyclic carbamate compounds as protease inhibitors , useful for inhibiting the development of drug resistance of HIV in HIV infected animals; improved pharmacokinetics; protease inhibitors |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070905 An enzyme in the tryptophan degradation pathway, used to treat neurodegenerative disorders, certain cancers, drug addiction; 2-sulfonamido-substituted oxazole, imidazole or thiazole compounds such as 3,4-dimethoxy-N-[4-(3-nitrophenyl)-5-dimethylaminomethyl-1,3-thiazole-2-yl]benzenesulfonamide |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070898 Sodium channel inhibitor of low side effect; analgesics; neuropathic pain; 4-(2-{4-[(E)-2-(2-methylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)morpholine for example |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | CA2663280A1 Diaryl piperidine compounds as calcium channel blockers |
| 03/20/2008 | CA2663189A1 Benzimidazolone derivatives |
| 03/20/2008 | CA2663178A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | CA2663159A1 Organic compounds and their uses |
| 03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 03/20/2008 | CA2661951A1 Substituted amides, method of making, and method of use thereof |
| 03/20/2008 | CA2661654A1 Certain substituted amides, method of making, and method of use thereof |
| 03/20/2008 | CA2660987A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 03/19/2008 | EP1900729A1 Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors |
| 03/19/2008 | EP1899331A1 Homomorpholine oxazolidinones as antibacterial agents |
| 03/19/2008 | EP1899330A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 03/19/2008 | EP1899329A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 03/19/2008 | EP1899326A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1899325A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 03/19/2008 | EP1899322A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 03/19/2008 | EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1899305A1 Helix 12 directed non-steroidal antiandrogens |
| 03/19/2008 | EP1899296A1 Histamine-3 receptor antagonists |
| 03/19/2008 | EP1660487B1 Pyrrole compositions useful as inhibitors of c-met |
| 03/19/2008 | EP1646613B1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | CN101146802A Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
| 03/19/2008 | CN101146801A New salt and polymorphs of a dpp-iv inhibitor |
| 03/19/2008 | CN101146799A Cgrp-antagonists, process for their preparation as well as their use as medicaments |
| 03/19/2008 | CN101146797A 4-2-(cycloalkylamino)pyrimidin-4-YL!- (phenyl)- imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
| 03/19/2008 | CN101146793A Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity |
| 03/19/2008 | CN101146776A PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/19/2008 | CN101146770A 2-phenyl-indoles as prostaglandin D2 receptor antagonists |
| 03/19/2008 | CN101146769A Azolylacylguanidines as beta-secretase inhibitors |
| 03/19/2008 | CN101146540A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/19/2008 | CN101146530A 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 03/19/2008 | CN101146529A Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 03/19/2008 | CN101143854A Synthesis method for dibenzoxazole compounds |
| 03/19/2008 | CN101143830A Organic electroluminescent material and application thereof |
| 03/18/2008 | USRE40156 Methods for repairing damaged intervertebral discs |
| 03/18/2008 | US7345085 Indoles having anti-diabetic activity |
| 03/18/2008 | US7345080 For arachnids and nematodes |
| 03/18/2008 | US7345070 Side effects reduction; Diabetes mellitus, Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; 3-{4-[2-(2-phenyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345049 Phenylalanine derivatives |
| 03/18/2008 | US7345038 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 03/18/2008 | US7345009 Substituted 4-hetaryl-pyrazolines as pest control agents |
| 03/18/2008 | CA2315927C Oral pharmaceutical pulsed release dosage form |
| 03/18/2008 | CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008030520A1 Heterocyclic gpr40 modulators |
| 03/13/2008 | WO2008030466A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/13/2008 | WO2008030369A1 Inhibitors of 5 -lipoxygenase activating protein ( flap) |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029371A1 Pyridin-4-yl derivatives as immunomodulating agents |
| 03/13/2008 | WO2008029370A1 Pyridin-3-yl derivatives as immunomodulating agents |
| 03/13/2008 | WO2008029306A2 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 03/13/2008 | WO2008029266A1 Stearoyl coa desaturase inhibitors |
| 03/13/2008 | WO2008028624A1 Fungicides |
| 03/13/2008 | WO2008028590A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 03/13/2008 | WO2007146376A3 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 03/13/2008 | WO2007136302A8 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 03/13/2008 | WO2007135527A3 Benzimidazolyl compounds |
| 03/13/2008 | WO2007130820A3 Mglur5 modulators i |
| 03/13/2008 | WO2007053819A3 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 03/13/2008 | WO2007010235A8 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide |
| 03/13/2008 | US20080064887 Paclitaxel or docetaxel synthesis and claimed intermediates; purity; coupling 7,10-diprotected intermediates 7-O-(2-haloacyl)baccatin III or 7,10-O-di-(2-haloacyl)-10-deacetylbaccatin III to 3-[(2-alkyl/aryl-2-trialkylsilyl)ethoxy-carbonyl]-4-aryl-2-substituted-1,3-oxazolidine-5-carboxylic acid |
| 03/13/2008 | US20080064880 Compounds That Absorb Ultraviolet Light, Methods of Their Preparation and Optical Lenses Containing Them |
| 03/13/2008 | US20080064873 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
| 03/13/2008 | US20080064872 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
| 03/13/2008 | US20080064734 Mixture with other active materials; controlling glucose metabolism; diabetes |
| 03/13/2008 | US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors |
| 03/13/2008 | US20080064698 1-Phenyl and 1-Pyridylpyrazole Derivatives and Their Use as Pesticides |
| 03/13/2008 | US20080064697 Antidiabetic agents; somatostatin receptor subtype 5 modulators; noninsulin dependent diabetes mellitus; side effect reduction; synthesis |
| 03/13/2008 | US20080064696 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/13/2008 | US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064689 Containing substituted oxazolidinone and isoxazoline rings; effective against antibiotic resistance strains; gram positive and Gram negative pathogens |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064682 1,5-diaryl-3-N-heterocycylcarbonylpyrazoles; antiagglomerants that do not inhibit cyclooxygenases; antiischemic agents |
| 03/13/2008 | US20080064679 Water Soluble Cannabinoids |
| 03/13/2008 | US20080064667 5,8-bis(dimethylamino)-2-(2,2-diphenylvinyl)-9,11a,12-trihydroxy-11,13-dioxo-6,6a,7,7a,8,11,11a,13-octahydrotetraceno[2,1-d][1,3]oxazole-10-carboxamide; effective against minocycline- and tetracycline-resistant bacteria |
| 03/13/2008 | US20080064600 N-((4,6-dimethoxypyrimidin-2-aminocarbonyl)-3-chloro-1-methyl-4-(5-methyl-5H,6H-1,4,2-dioxadin-3-yl)pyrazole-5-sulfonamide; synergistic and selective, ideal for paddy rice, wheat or barley |
| 03/13/2008 | CA2666686A1 Inhibitors of 5-lipoxygenase activating protein (flap) |
| 03/13/2008 | CA2662728A1 Substituted bipyridine derivatives and their use |
| 03/13/2008 | CA2662259A1 Fungicides |